SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs AI-CVD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

AI-CVD

by HeartLung AI

AI Verdict

Tool A assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope, providing real-time decision support during auscultation. In contrast, Tool B performs opportunistic screening for cardiovascular and multisystem diseases by analyzing existing CT scans. While both are FDA-cleared Cardiology AI tools, they serve distinct clinical workflows and utilize entirely different data modalities (acoustic vs. imaging) for their respective purposes.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SensiCardiac Mobi if you need real-time, point-of-care AI assistance during a physical examination to differentiate between physiological and pathological heart murmurs. This tool is ideal for physicians seeking immediate diagnostic support when auscultating a patient with a compatible electronic stethoscope.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose AI-CVD if…

Choose AI-CVD if you aim to opportunistically screen for a wide range of cardiovascular and multisystem diseases using existing CT scans. This platform is best suited for identifying hidden health risks and quantifying various cardiac and vascular parameters without requiring additional imaging or patient contact.

View AI-CVD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	AI-CVD
Pricing	Contact for pricing	Unknown
Deployment	Hosted server environment (Linux OS) with a mobile application interface	Unknown
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Unknown
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AI-CVD

While SensiCardiac Mobi offers a user-friendly mobile application with guided auscultation for real-time interaction, AI-CVD excels in integrating seamlessly into existing radiology workflows. Its ability to leverage already acquired CT scans without requiring additional imaging or workflow disruption minimizes the burden on healthcare providers.

Clinical Value

AI-CVD

AI-CVD provides a broader and more comprehensive clinical value by performing opportunistic screening for a wide array of cardiovascular and multisystem diseases from existing CT scans. This approach allows for early detection of hidden health risks across multiple organ systems, significantly expanding its potential impact on patient care beyond a single diagnostic focus.

Pricing & Value

Tie

Both tools require direct contact with the vendor for pricing information, making it impossible to compare their cost-effectiveness or overall value proposition transparently. Without publicly available pricing or detailed return on investment studies, a definitive winner cannot be determined for this dimension.

Enterprise Readiness

AI-CVD

Both tools are FDA-cleared, and both explicitly state HIPAA compliance. However, AI-CVD's cloud-based deployment inherently offers greater scalability and accessibility for enterprise-wide adoption. Its design to integrate with existing CT scan workflows across millions of scans further enhances its readiness for widespread implementation in large healthcare systems.

Innovation

AI-CVD

AI-CVD demonstrates greater innovation by leveraging existing CT scans to opportunistically screen for a broad spectrum of cardiovascular and multisystem diseases. This approach maximizes the utility of already acquired data, enabling early detection of previously hidden risks without imposing additional imaging burden or workflow changes.

Support & Docs

AI-CVD

HeartLung Corporation's AI-CVD provides more explicit indications of support and documentation through its 'Knowledge Center' and 'Resources' sections on its website, along with direct contact information. In contrast, specific details regarding support channels, documentation quality, or training programs for SensiCardiac Mobi are not readily available in the provided information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	AI-CVD
Name	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	AI-CVD
Company	DIACOUSTIC MEDICAL DEVICES (PTY)	HeartLung Corporation
Description	SensiCardiac Mobi is an FDA-cleared AI-powered mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds.	AI-CVDu00ae is an FDA-cleared, AI-powered quantitative imaging platform from HeartLung Corporation that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks.
Categories	Cardiology AI, Clinical Decision Support & Reference	Cardiology AI
Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Pulmonology, Radiology
Key Features	Acquires and records acoustic heart signals, Analyzes heart sounds using the Sensi Diagnostic Heart Murmur Algorithm, Distinguishes between normal/physiological and pathological heart murmurs, Identifies S1, S2, and suspected murmurs, Records heart sounds at four main auscultation positions, Mobile application for data capture and display (e.g., iPhone 4S or later), Requires a compatible electronic stethoscope (user-provided), Operates as a decision support software, complementing physician assessment	Automated CT-derived anatomical and density-based measurements, Opportunistic screening from existing chest and abdominal CT scans, No additional imaging, radiation, contrast, or workflow disruption, Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and AI-CVD.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do SensiCardiac Mobi and AI-CVD integrate into a physician's existing clinical workflow?

SensiCardiac Mobi integrates by assisting during live auscultation, requiring an electronic stethoscope and a mobile application for real-time heart sound analysis. AI-CVD, conversely, operates opportunistically by analyzing existing chest and abdominal CT scans, aiming for early disease detection without disrupting current imaging workflows or requiring additional patient procedures.

What specific clinical insights and decision support do these tools offer to aid in patient assessment?

SensiCardiac Mobi provides real-time decision support by analyzing acoustic heart signals to differentiate between physiological and pathological heart murmurs, identifying S1, S2, and suspected murmurs. AI-CVD offers quantitative imaging insights from existing CT scans, including coronary artery calcium scoring, cardiac chamber volumetry, and aortic/mitral valve calcium analysis, to identify hidden cardiovascular and multisystem disease risks.

What is the expected learning curve for physicians and their staff to effectively utilize each tool?

For SensiCardiac Mobi, the learning curve involves familiarization with its mobile application interface and the proper technique for acquiring heart sounds with a compatible electronic stethoscope. AI-CVD, being a cloud-based quantitative imaging platform, would likely require training on interpreting its automated CT-derived measurements and integrating these findings into radiological or cardiological reports.

Which medical specialties are best suited for each tool, and what is their primary clinical application?

SensiCardiac Mobi is primarily designed for Cardiology, Internal Medicine, and Pediatrics, assisting in the diagnosis and differentiation of heart murmurs during auscultation. AI-CVD is best suited for Cardiology, Pulmonology, and Radiology, focusing on opportunistic screening for cardiovascular and multisystem diseases using existing CT scans to enable early detection.

What are the key considerations for deploying these tools across multiple clinical sites or hospital systems?

For SensiCardiac Mobi, multi-site deployment would involve distributing the mobile application and ensuring compatible electronic stethoscopes are available and integrated with its hosted server environment across sites. AI-CVD, being a cloud-deployed platform, generally offers more streamlined multi-site rollout, as it can be accessed remotely and integrated with existing PACS/EHR systems across different locations.

Beyond standard compliance, what specific security features or audit capabilities do these tools offer for patient data?

SensiCardiac Mobi operates within a hosted server environment (Linux OS), which implies a focus on server-level security for recorded acoustic heart signals. AI-CVD, as a cloud-deployed platform, would typically leverage robust cloud security frameworks for protecting quantitative imaging data derived from CT scans, though specific audit features are not detailed in the provided information.